Humacyte, Inc. Earnings Per Share (Basic)
Humacyte, Inc. (HUMA) reported Earnings Per Share (Basic) of -$0.16 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Humacyte, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.16.
- Humacyte, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.09, a 132.14% decline year-over-year.
- Humacyte, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.11.
- Humacyte, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.24.
- Humacyte, Inc. earnings per share, basic for fiscal 2025 was -$0.26.
- Humacyte, Inc. earnings per share, basic for fiscal 2024 was -$1.26.
- Humacyte, Inc. earnings per share, basic for fiscal 2023 was -$1.07.
- Humacyte, Inc. earnings per share, basic for fiscal 2022 was -$0.12.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.16 10-Q · filed 2026-08-12 | -$0.25 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.09 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | -$0.26 10-K · filed 2026-03-27 | |||
| 2025-09-30 | -$0.11 10-Q · filed 2025-11-12 | -$0.11 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$0.24 10-Q · filed 2026-08-12 | $0.01 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $0.28 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$1.26 10-K · filed 2026-03-27 | |||
| 2024-09-30 | -$0.33 10-Q · filed 2025-11-12 | -$1.10 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.48 10-Q · filed 2025-08-11 | -$0.78 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$0.29 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | -$1.07 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$0.25 10-Q · filed 2024-11-08 | -$0.83 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | -$0.22 10-Q · filed 2024-08-13 | -$0.58 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$0.36 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$0.12 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$0.25 10-Q · filed 2023-11-09 | -$0.08 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.36 10-Q · filed 2023-08-14 | $0.17 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.19 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | -$0.66 10-K · filed 2023-03-24 | |||
| 2021-09-30 | -$0.72 10-Q · filed 2022-11-10 | -$3.69 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$2.89 10-Q · filed 2022-08-12 | -$6.35 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$3.46 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | -$11.54 10-K · filed 2022-03-29 | |||
| 2020-09-30 | -$3.07 10-Q · filed 2021-11-15 | -$8.74 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |